ADC Therapeutics S.A.
NYSE:ADCTBiotechnology
Healthcare
$1.37 -1.35%
-$0.02 today
- Market cap
- $192.71M
- Beta
- 1.77
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.89
52W Low $0.78High $4.98
Volume 1.17M
Average 1.68M
Price history
ADC Therapeutics S.A. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-65.75%
Period high
$4.88
Period low
$0.96
Latest
$1.37
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| S-3 | Nov 10, 2026 | Nov 9, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| S-4 | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13G | Oct 29, 2026 | Oct 29, 2026 | |
| 8-K | Oct 13, 2026 | Oct 13, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| S-8 | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 |
Competitors
Who does ADC Therapeutics S.A. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ADCT's filings, answered from its disclosures.
What is the latest ADCT filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does ADCT have?
Intrinsic Alpha currently shows 20 recent filings for ADCT.
Continue the stock analysis
Jump to another research area for this company.